Skip to main content
HRTX logo

HRTX · Heron Therapeutics, Inc. · Held by Funds

Track HRTX — free
$0.27 +0.01 (+2.23%) Play latest call Q2 2026 earnings call transcript
Market Cap
$50.25M
Shares
190.27M
Volume · Nov 19 3.61M Avg daily vol (3M) 4.54M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of HRTX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 11.43% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.73% 5,194,801
Index ETFs 8.70% 16,559,897
Active ETFs 0.00% 4,190
Active funds 0.44% 838,244
Unclassified 0.42% 806,857
All registered funds 12.30% 23,403,989
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding HRTX

102 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 102 positions
Key facts CIK 818033 CUSIP 427746102 13F (30d) 157 filings 141 filers Visit website Investor relations